Literature DB >> 9927229

The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation.

W E Longo1, B Erickson, N Panesar, J E Mazuski, S Robinson, D L Kaminski.   

Abstract

Intestinal smooth muscle plays a major role in the repair of injured intestine and contributes to the prostanoid pool during intestinal inflammatory states. Cyclooxygenase (COX), which catalyzes the conversion of arachidonic acid to prostanoids exists in two isoforms, COX-1 and COX-2. The purpose of this study was to determine the relative contributions of COX-1 and COX-2 in the production of prostanoids by human intestinal smooth muscle (HISM) cells when stimulated by interleukin-1beta (IL-1beta) and lipopolysaccharide (LPS). Furthermore the effects of specific COX-1 and COX-2 inhibitors on the proliferation of smooth muscle cells was also evaluated. Confluent monolayer cultures of HISM cells were incubated with IL-1beta or LPS for 0-24h while control cells received medium alone. PGE2 and PGI2 as 6-keto-PGF1alpha and LTB4 were measured by a specific radioimmunoassay. COX enzymes were evaluated by Western immunoblotting. Unstimulated and stimulated cells were exposed to the specific COX-1 inhibitor valerylsalicylic acid (VSA) and the COX-2 inhibitors NS-398 and SC-58125. The effects of serum on proliferation were then evaluated in the presence of each of the specific COX inhibitors by incorporation of 3H-thymidine into DNA. IL-1beta and LPS increased both PGE2 and 6-keto-PGF1alpha in a dose dependent fashion with enhanced production detected two hours following exposure. Neither stimulus stimulated LTB4 release. Immunoblot analysis using isoform-specific antibodies showed that both COX-1 and COX-2 were present constitutively. Furthermore, COX-1 was upregulated by each inflammatory stimulus. In a separate set of experiments cells were pretreated with either the selective COX-1 inhibitor VSA or the selective COX-2 inhibitors NS-398 or SC-58125 prior to treatment with IL-1beta or LPS. The COX-1 and COX-2 inhibitors decreased both basal and IL-1beta and LPS stimulated prostanoid release. Spontaneous DNA synthesis was present and serum consistently increased proliferation. 3H-thymidine incorporation, stimulated by serum, was inhibited by both COX-1 and COX-2 inhibitors. This study suggests that the prostanoid response stimulated by proinflammatory agents of gut-derived smooth muscle cells appears to be mediated by both COX-1 and COX-2 enzymes. Proliferation of smooth muscles cells also appears to be influenced by both COX-1 and COX-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9927229      PMCID: PMC1781872          DOI: 10.1080/09629359890749

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  21 in total

Review 1.  Prostaglandin endoperoxide synthase: structure and catalysis.

Authors:  W L Smith; L J Marnett
Journal:  Biochim Biophys Acta       Date:  1991-04-24

2.  Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells.

Authors:  Y L Dong; P R Gangula; L Fang; C Yallampalli
Journal:  Prostaglandins       Date:  1996-07

3.  Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

Authors:  B K Reuter; S Asfaha; A Buret; K A Sharkey; J L Wallace
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  Inducible cyclooxygenase and nitric oxide synthase.

Authors:  K K Wu
Journal:  Adv Pharmacol       Date:  1995

Review 5.  Prostaglandin synthase 2.

Authors:  H R Herschman
Journal:  Biochim Biophys Acta       Date:  1996-01-05

6.  Studies of prostaglandins and sulphasalazine in ulcerative colitis.

Authors:  S R Gould; A R Brash; M E Conolly; J E Lennard-Jones
Journal:  Prostaglandins Med       Date:  1981-02

7.  Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation.

Authors:  M W Owens; M B Grisham
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

8.  The effect of trinitrobenzene sulfonic acid (TNB) on colonocyte arachidonic acid metabolism.

Authors:  M D Stratton; R Sexe; B Peterson; D L Kaminski; A P Li; W E Longo
Journal:  J Surg Res       Date:  1996-02-01       Impact factor: 2.192

9.  Interleukin 1 beta down-regulates collagen and augments collagenase expression in human intestinal smooth muscle cells.

Authors:  M F Graham; A Willey; J Adams; D Yager; R F Diegelmann
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

10.  Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo.

Authors:  K A Pritchard; M K O'Banion; J M Miano; N Vlasic; U G Bhatia; D A Young; M B Stemerman
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  2 in total

1.  Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion.

Authors:  Byron L Sparkes; Emily E Archer Slone; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Biochim Biophys Acta       Date:  2010-01-18

2.  Phospholipid scramblase 1 is required for β2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation.

Authors:  Emily Archer Slone; Michael R Pope; Sherry D Fleming
Journal:  J Leukoc Biol       Date:  2015-07-27       Impact factor: 4.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.